Tags

Type your tag names separated by a space and hit enter

Extracorporeal membrane oxygenation (ECMO) - in the treatment of severe, life-threatening respiratory failure.
Wiad Lek. 2019; 72(9 cz 2):1822-1828.WL

Abstract

Extracorporeal membrane oxygenation (ECMO) is a technique involving oxygenation of blood and elimination of carbon dioxide in patients with life-threatening, but potentially reversible conditions. Thanks to the modification of extracorporeal circulation used during cardiac surgeries, this technique can be used in intensive care units. Venovenous ECMO is used as a respiratory support, while venoarterial ECMO as a cardiac and/or respiratory support. ECMO does not cure the heart and/or lungs, but it gives the patient a chance to survive a period when these organs are inefficient. In addition, extracorporeal membrane oxygenation reduces or eliminates the risk of lung damage associated with invasive mechanical ventilation in patients with severe ARDS (acute respiratory distress syndrome). ECMO is a very invasive therapy, therefore it should only be used in patients with extremely severe respiratory failure, who failed to respond to conventional therapies. According to the Extracorporeal Life Support Organization (ELSO) Guidelines, inclusion criteria are: PaO2 / FiO2 < 80 for at least 3 hours or pH < 7.25 for at least 3 hours. Proper ECMO management requires advanced medical care. This article discusses the history of ECMO development, clinical indications, contraindications, clinical complications and treatment outcomes.

Authors+Show Affiliations

Students' Scientific Society, Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.Students' Scientific Society, Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.Department of General, Endocrine and Vascular Surgery, Medical University of Warsaw, Warsaw, Poland.Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.Department of Cardiac Anesthesia and Intensive Therapy, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31622273

Citation

Ślusarz, Krystian, et al. "Extracorporeal Membrane Oxygenation (ECMO) - in the Treatment of Severe, Life-threatening Respiratory Failure." Wiadomosci Lekarskie (Warsaw, Poland : 1960), vol. 72, no. 9 cz 2, 2019, pp. 1822-1828.
Ślusarz K, Kurdyś P, Armatowicz P, et al. Extracorporeal membrane oxygenation (ECMO) - in the treatment of severe, life-threatening respiratory failure. Wiad Lek. 2019;72(9 cz 2):1822-1828.
Ślusarz, K., Kurdyś, P., Armatowicz, P., Knapik, P., & Trejnowska, E. (2019). Extracorporeal membrane oxygenation (ECMO) - in the treatment of severe, life-threatening respiratory failure. Wiadomosci Lekarskie (Warsaw, Poland : 1960), 72(9 cz 2), 1822-1828.
Ślusarz K, et al. Extracorporeal Membrane Oxygenation (ECMO) - in the Treatment of Severe, Life-threatening Respiratory Failure. Wiad Lek. 2019;72(9 cz 2):1822-1828. PubMed PMID: 31622273.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Extracorporeal membrane oxygenation (ECMO) - in the treatment of severe, life-threatening respiratory failure. AU - Ślusarz,Krystian, AU - Kurdyś,Paulina, AU - Armatowicz,Paul, AU - Knapik,Piotr, AU - Trejnowska,Ewa, PY - 2019/10/18/entrez PY - 2019/10/18/pubmed PY - 2019/11/8/medline KW - acute cardiac failure KW - acute respiratory distress syndrome KW - acute respiratory failure KW - critical care KW - extracorporeal membrane oxygenation SP - 1822 EP - 1828 JF - Wiadomosci lekarskie (Warsaw, Poland : 1960) JO - Wiad Lek VL - 72 IS - 9 cz 2 N2 - Extracorporeal membrane oxygenation (ECMO) is a technique involving oxygenation of blood and elimination of carbon dioxide in patients with life-threatening, but potentially reversible conditions. Thanks to the modification of extracorporeal circulation used during cardiac surgeries, this technique can be used in intensive care units. Venovenous ECMO is used as a respiratory support, while venoarterial ECMO as a cardiac and/or respiratory support. ECMO does not cure the heart and/or lungs, but it gives the patient a chance to survive a period when these organs are inefficient. In addition, extracorporeal membrane oxygenation reduces or eliminates the risk of lung damage associated with invasive mechanical ventilation in patients with severe ARDS (acute respiratory distress syndrome). ECMO is a very invasive therapy, therefore it should only be used in patients with extremely severe respiratory failure, who failed to respond to conventional therapies. According to the Extracorporeal Life Support Organization (ELSO) Guidelines, inclusion criteria are: PaO2 / FiO2 < 80 for at least 3 hours or pH < 7.25 for at least 3 hours. Proper ECMO management requires advanced medical care. This article discusses the history of ECMO development, clinical indications, contraindications, clinical complications and treatment outcomes. SN - 0043-5147 UR - https://www.unboundmedicine.com/medline/citation/31622273/Extracorporeal_membrane_oxygenation__ECMO____in_the_treatment_of_severe_life_threatening_respiratory_failure_ L2 - https://medlineplus.gov/respiratoryfailure.html DB - PRIME DP - Unbound Medicine ER -